Cancer news and cancer widget

St. Baldrick's Foundation, a non-profit organization dedicated to raising money for childhood cancer research, awarded $330,000 to fund Alex Huang, M.D., Ph.D., of Case Western Reserve University School of medicine as a St. Baldrick's Scholar for three years. St. Baldrick's began as a challenge between friends, and has exploded into the world's largest volunteer-driven fundraising program for childhood cancer research.

Frank L. Meyskens, Jr., M.D., one of the "fathers" of the field of cancer chemoprevention, has been selected to receive the seventh annual American Association for Cancer Research (AACR)-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research. The award is given annually to a scientist for seminal contributions to the field of cancer prevention research in basic, translational, clinical, epidemiological or behavioral science.

A team of scientists from the UK and other European countries has created a genetically modified (GM) purple tomato that in a pilot test significantly extended the life span of cancer-susceptible mice that were fed the new tomatoes compared to mice that were fed normal tomatoes.

Viruses - long regarded solely as disease agents - now are being used in therapies for cancer. Concerns over the safety of these so-called oncolytic viruses stem from their potential to damage healthy tissues. Now Mayo Clinic researchers have discovered a way of controlling the viruses behind potential cancer therapeutics. They are engineering the virus's genetic sequence, using microRNAs to restrict them to specific tissues.

UroToday.com - In the online edition of The Prostate, Robert S. DiPaola and co-investigators reported their research on autophagy. Autophagy is a mechanism of cellular resistance or alternatively cell death. cancer metabolism differs from normal cells in that it uses anaerobic glycolysis as opposed to oxidative phosphorylation to metabolize glucose.

I often receive emails asking what can or cannot cause cancer. By far, one of the most common questions involve tattoos. Tattoos are becoming increasingly popular among people of all...

Did you know that the most common and greatest risk factors for developing gallbaldder cancer is having gallstones? Gallstones are deposits of calcium or cholesterol that settle in the gallbladder...

Women especially need to be aware of any signs and symptoms their bodies may be exhbiting. Many types of gynecologic cancer produce symptoms early enough for them to be successfully...

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today presented, for the first time, results of studies on its investigational, multi-targeted kinase inhibitor - AP24534 - showing anti-tumor activity in preclinical cancer models. These data were released at the EORTC-NCI-AACR (ENA) symposium on "Molecular Targets and Cancer Therapeutics" held in Geneva, Switzerland this week.

Scientists in the USA were asked in 2006 to give priority treatment to glioblastoma brain tumours and this week the prestigious Nature magazine carried information from The cancer Genome Atlas (TCGA) Research Network about the identification of key genetic characteristics which could lead to more beneficial targeted therapies.